Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses

American Journal of Veterinary Research

Volumn 69, Issue 2, 2008, Pages 199-207

  Menzies Gow, Nicola J ^a   Sepulveda, M Fernanda ^a   Bailey, Simon R ^a   Cunningham, Fiona M ^a   Elliott, Jonathan ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; ACETYLSALICYLIC ACID; APAFANT; ENDOTOXIN; FLUNIXIN MEGLUMINE; LIPOPOLYSACCHARIDE; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; 3 (3 (DIMETHYLAMINO)PROPYL) 4 HYDROXY N (4 (4 PYRIDINYL)PHENYL)BENZAMIDE; 3-(3-(DIMETHYLAMINO)PROPYL)-4-HYDROXY-N-(4-(4-PYRIDINYL)PHENYL)BENZAMIDE; AZEPINE DERIVATIVE; BENZAMIDE DERIVATIVE; CALCIMYCIN; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; PYRIDINE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIAZOLE DERIVATIVE; TRYPTAMINE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTERY BLOOD FLOW; ARTICLE; BLOOD SAMPLING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; FOOT PAD; FOOT SOLE; HORSE DISEASE; HYPOTHERMIA; LEUKOCYTE; LIMB PERFUSION; MALE; MONOTHERAPY; NONHUMAN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; VASOCONSTRICTION; VEIN BLOOD FLOW; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HORSE; METABOLISM; PHYSIOLOGY; TIME;

ANIMALIA; EQUIDAE;

ANIMALS; ASPIRIN; AZEPINES; BENZAMIDES; BLOOD PLATELETS; CALCIMYCIN; FEMALE; HORSES; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; SEROTONIN; THROMBOXANE A2; TIME FACTORS; TRIAZOLES; TRYPTAMINES; VASOCONSTRICTION;

EID: 39549088881     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.2.199     Document Type: Article

References (57)

1. Schmidt W, Tinelli M, Secchi A, et al. Influence of amrinone on intestinal villus blood flow during endotoxemia. J Crit Care 2000;15:97-102.
2. Eades SC, Moore JN. Blockade of endotoxin-induced cecal hypoperfusion and ileus with an alpha 2 antagonist in horses. Am J Vet Res 1993;54:586-590.
3. Avontuur JA, Bruining HA, Ince C. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995;76:418-425.
4. Ando M, Takashima S, Mito T. Endotoxin, cerebral blood flow, amino acids and brain damage in young rabbits. Brain Dev 1988;10:365-370.
5. Gullichsen E. Renal perfusion and metabolism in experimental endotoxin shock. Acta Chir Scand 1991;560:7-31.
6. van Lambalgen AA, van den Bos GC, Thijs LG. Blood flow and plasma extravasation in skeletal muscle during endotoxemia. A study in rats. Int J Microcirc Clin Exp 1989;8:217-232.
7. Hunt JM, Edwards GB, Clarke KW. Incidence, diagnosis and treatment of postoperative complications in colic cases. Equine Vet J 1986;18:264-270.
8. Olson NC, Hellyer PW, Dodam JR. Mediators and vascular effects in response to endotoxin. Br Vet J 1995;151:489-522.
9. Menzies-Gow NJ, Bailey SR, Katz LM, et al. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet J 2004;36:273-278.
10. Sprouse RF, Garner HE, Green EM. Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis. Equine Vet J 1987;19:25-28.
11. Steverink PJ, Salden HJ, Sturk A, et al. Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders. Vet Q 1994;16(suppl 2):S117-S121.
12. Jarvis GE, Evans RJ. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Res Vet Sci 1994;57:317-324.
13. Bailey SR, Andrews MJ, Elliott J, et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. Res Vet Sci 2000;68:175-180.
14. Jarvis GE, Evans RJ. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Blood Coagul Fibrinolysis 1996;7:194-198.
15. Bottoms GD, Johnson M, Ward D, et al. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187. Circ Shock 1986;20:25-34.
16. Lees P, Ewins CP, Taylor JB, et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. Br Vet J 1987;143:462-476.
17. Bailey SR, Elliott J. Evidence for different 5-HT1B/1D receptors mediating vasoconstriction of equine digital arteries and veins. Eur J Pharmacol 1998;355:175-187.
18. Yildiz O, Tuncer M. Amplification of responses to sumatriptan by various agonists in rabbit isolated iliac artery. J Cardiovasc Pharmacol 1995;25:508-510.
19. Young MS, Iwanov V, Moulds RF. Interaction between platelet-released serotonin and thromboxane A2 on human digital arteries. Clin Exp Pharmacol Physiol 1986;13:143-152.
20. 1B receptor. Br J Pharmacol 1999;128:730-734.
21. Carrick JB, Morris DD, Moore JN. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia. Equine Vet J 1993;25:152-157.
22. 1β, tumour necrosis factor, or IFN-γ. J Immunol 1988;141:3945-3950.
23. Foster AP, Lees P, Andrews MJ, et al. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Equine Vet J 1992;24:203-207.
24. Bailey SR, Cunningham FM, Elliott J. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse. Equine Vet J 2000;32:497-504.
25. Elliott J, Berhane Y, Bailey SR. Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. Am J Vet Res 2003;64:1124-1131.
26. Bailey SR, Menzies-Gow NJ, Marr CM, et al. The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Equine Vet J 2004;36:267-272.
27. Cambridge H, Lees P, Hooke RE, et al. Antithrombotic actions of aspirin in the horse. Equine Vet J 1991;23:123-127.
28. Hood DM, Wagner IP, Brumbaugh GW. Evaluation of hoof wall surface temperature as an index of digital vascular perfusion during the prodromal and acute phases of carbohydrate-induced laminitis in horses. Am J Vet Res 2001;62:1167-1172.
29. Bailey SR, Elliott J. Plasma 5-hydroxytryptamine constricts equine digital blood vessels in vitro: implications for pathogenesis of acute laminitis. Equine Vet J 1998;30:124-130.
30. Ewer AK, Al-Salti W, Coney AM, et al. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 2004;53:207-213.
31. Bailey SR, Wheeler-Jones C, Elliott J. Uptake of 5-hydroxytryptamine by equine digital vein endothelial cells: inhibition by amines found in the equine caecum. Equine Vet J 2003;35:164-169.
32. Fairbairn SM, Marr KA, Lees P, et al. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease. Res Vet Sci 1996;61:107-113.
33. Walker M, Geiser D. Effects of acetylpromazine on the hemodynamics of the equine metatarsal artery, as determined by two-dimensional real-time and pulsed Doppler ultrasonography. Am J Vet Res 1986; 47:1075-1078.
34. Cochard T, Toal RL, Saxton AM. Doppler ultrasonographic features of thoracic limb arteries in clinically normal horses. Am J Vet Res 2000;61:183-190.
35. Hoffmann KL, Wood AK, Griffiths KA, et al. Doppler sonographic measurements of arterial blood flow and their repeatability in the equine foot during weight bearing and non-weight bearing. Res Vet Sci 2001;70:199-203.
36. Raisis AL, Young LE, Blissitt KJ, et al. A comparison of the haemodynamic effects of isoflurane and halothane anaesthesia in horses. Equine Vet J 2000c;32:318-326.
37. Raisis AL, Young LE, Blissitt KJ, et al. Effect of a 30-minute infusion of dobutamine hydrochloride on hind limb blood flow and hemodynamics in halothane-anesthetized horses. Am J Vet Res 2000;61:1282-1288.
38. Gill RW. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol 1985;11:625-641.
39. Lewis P, Psaila JV, Davies WT, et al. Measurement of volume flow in the human common femoral artery using a duplex ultrasound system. Ultrasound Med Biol 1986;12:777-784.
40. Menzies-Gow NJ, Marr CM. The repeatability of Doppler ultrasonographic measurement of equine digital blood flow. Vet Radiol Ultrasound 2007;48:281-285.
41. Hood DM, Brumbaugh GW, Wagner IP. Effectiveness of a unique dihydropyridine (BAYTG 1000) for prevention of laminitis in horses. Am J Vet Res 2002;63:443-447.
42. Hoff TK, Hood DM, Wagner IP. Effectiveness of glyceryl trinitrate for enhancing digital submural perfusion in horses. Am J Vet Res 2002;63:648-652.
43. Ingle-Fehr JE, Baxter GM. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Am J Vet Res 1998;59:192-196.
44. Hunt RJ, Alien D, Moore JN. Effect of endotoxin administration on equine digital hemodynamics and starling forces. Am J Vet Res 1990;51:1703-1707.
45. Bailey SR, Elliott J. The role of prostanoids and nitric oxide in endotoxin-induced hyporesponsiveness of equine digital blood vessels. Equine Vet J 1999;31:212-218.
46. Baxter GM, Moore JN. Effect of aspirin on ex vivo generation of thromboxane in healthy horses. Am J Vet Res 1987;48:13-16.
47. Saeed S, Rasheed H, Gilani A. Synergism interaction between arachadonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways. Acta Pharmacol Sin 2003;24:958-964.
48. Hernanz R, Alonso MJ, Briones AM, et al. Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries. Br J Pharmacol 2003;140:671-680.
49. Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2 and specific receptor anatagonists on vascular smooth muscle cell proliferation. Circulation 1997;96:2280-2286.
50. Brooks A, Menzies-Gow NJ, Bailey SR, et al. Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production. Inflamm Res 2007;56:154-161.
51. Nakamura M, Honda Z, Waga I, et al. Endotoxin transduces Ca2+ signalling via platelet-activating factor receptor. FEBS Lett 1992;314:125-129.
52. Cognasse F, Hamzeh H, Chavarin P, et al. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005;83:196-198.
53. Nemerson Y, Giesen PL. Some thoughts about localisation and expression of tissue factor. Blood Coagul Fibrinolysis 1998;9: S45-S47.
54. Diacovo TG, Roth SJ, Bucola JM. Neutrophil rolling, arrest, and transmigration across activated, surface adherent platelets via sequential action of P-selectin and the β2-integrin CB11b/CD18. Blood 1996;88:146-157.
55. Celi A, Lorenzet R, Furie B, et al. Platelet-leucocyte-endothelial cell interaction on the blood vessel wall. Semin Hematol 1997;34:327-335.
56. Olson NC, Salzer WL, McCall CE. Biochemical, physiological and clinical aspects of endotoxemia. Mol Aspects Med 1988;10:511-629.
57. Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.